The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 12, 2023
Filed:
Jan. 28, 2022
Applicant:
Nantbio, Inc., Culver City, CA (US);
Inventors:
Clifford Anders Olson, Culver City, CA (US);
Kayvan Niazi, Culver City, CA (US);
Hermes J. Garban, Culver City, CA (US);
Raymond Wong, Los Angeles, CA (US);
Shiho Tanaka, Culver City, CA (US);
Assignee:
NantBio, Inc., Culver City, CA (US);
Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); A61K 47/68 (2017.01); C07K 14/725 (2006.01); C07K 14/54 (2006.01); C07K 14/715 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2803 (2013.01); A61K 47/6849 (2017.08); C07K 14/5443 (2013.01); C07K 14/7051 (2013.01); C07K 14/7155 (2013.01); C07K 2317/56 (2013.01); C07K 2319/30 (2013.01);
Abstract
Antibodies, fragments thereof, and chimeric proteins comprising same are presented that have specific binding activity against T-cell immunoglobulin mucin receptor 3 (TIM3). Advantageously, contemplated molecules can be used in pharmaceutical compositions for immune therapy, particularly in individuals receiving cancer vaccines and/or checkpoint inhibitor treatment.